The UK Department of Health and Social Care (DHSC) proposes £39 million ($48.5 million) of funding for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF). Of this new funding package, up to £24 million over four years has been awarded to bolster the UK's partnership with CARB-X – a global AMR research initiative – to support the continued early ... - The Pharma Letter